Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 252 entries
Sorted by: Best Match Show Resources per page
Commentary: Impact of a deletion of the full-length and short isoform of p75NTR on cholinergic innervation and the population of postmitotic doublecortin positive cells in the dentate gyrus.

Frontiers in neuroanatomy

Sabry MA, Fares M, Folkesson R, Al-Ramadan M, Alabkal J, Al-Kafaji G, Hassan M.
PMID: 26924966
Front Neuroanat. 2016 Feb 19;10:14. doi: 10.3389/fnana.2016.00014. eCollection 2016.

No abstract available.

Cite
Sabry MA, Fares M, Folkesson R, et al. Commentary: Impact of a deletion of the full-length and short isoform of p75NTR on cholinergic innervation and the population of postmitotic doublecortin positive cells in the dentate gyrus. Front Neuroanat. 2016;10:14doi: 10.3389/fnana.2016.00014.
Sabry, M. A., Fares, M., Folkesson, R., Al-Ramadan, M., Alabkal, J., Al-Kafaji, G., & Hassan, M. (2016). Commentary: Impact of a deletion of the full-length and short isoform of p75NTR on cholinergic innervation and the population of postmitotic doublecortin positive cells in the dentate gyrus. Frontiers in neuroanatomy, 1014. https://doi.org/10.3389/fnana.2016.00014
Sabry, Mohamed A, et al. "Commentary: Impact of a deletion of the full-length and short isoform of p75NTR on cholinergic innervation and the population of postmitotic doublecortin positive cells in the dentate gyrus." Frontiers in neuroanatomy vol. 10 (2016): 14. doi: https://doi.org/10.3389/fnana.2016.00014
Sabry MA, Fares M, Folkesson R, Al-Ramadan M, Alabkal J, Al-Kafaji G, Hassan M. Commentary: Impact of a deletion of the full-length and short isoform of p75NTR on cholinergic innervation and the population of postmitotic doublecortin positive cells in the dentate gyrus. Front Neuroanat. 2016 Feb 19;10:14. doi: 10.3389/fnana.2016.00014. eCollection 2016. PMID: 26924966; PMCID: PMC4759264.
Copy Download .nbib Format: NLM
Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease.

Experimental and therapeutic medicine

Salama M, Sobh M, Emam M, Abdalla A, Sabry D, El-Gamal M, Lotfy A, El-Husseiny M, Sobh M, Shalash A, Mohamed WM.
PMID: 28450929
Exp Ther Med. 2017 Mar;13(3):976-982. doi: 10.3892/etm.2017.4073. Epub 2017 Jan 20.

Parkinson's disease (PD) is the second most common neurodegenerative disease worldwide. It affects the locomotor system, leading to a final severe disability through degeneration of dopaminergic neurons. Despite several therapeutic approaches used, no treatment has been proven to be...

Cite
Salama M, Sobh M, Emam M, et al. Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease. Exp Ther Med. 2017;13(3):976-982doi: 10.3892/etm.2017.4073.
Salama, M., Sobh, M., Emam, M., Abdalla, A., Sabry, D., El-Gamal, M., Lotfy, A., El-Husseiny, M., Sobh, M., Shalash, A., & Mohamed, W. M. (2017). Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease. Experimental and therapeutic medicine, 13(3), 976-982. https://doi.org/10.3892/etm.2017.4073
Salama, Mohamed, et al. "Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease." Experimental and therapeutic medicine vol. 13,3 (2017): 976-982. doi: https://doi.org/10.3892/etm.2017.4073
Salama M, Sobh M, Emam M, Abdalla A, Sabry D, El-Gamal M, Lotfy A, El-Husseiny M, Sobh M, Shalash A, Mohamed WM. Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease. Exp Ther Med. 2017 Mar;13(3):976-982. doi: 10.3892/etm.2017.4073. Epub 2017 Jan 20. PMID: 28450929; PMCID: PMC5403256.
Copy Download .nbib Format: NLM
Seroepidemiological prevalence of hepatitis B virus markers in Eastern Saudi Arabia.

Saudi medical journal

Fathalla SE, Al-Jama AA, Al-Sheikh IH, El-Rifaei AM, Younis YS, Badawi MS, Kanaan AM, Sabry HS.
PMID: 27701543
Saudi Med J. 1998 May;19(3):283-288.

Full text is available as a scanned copy of the original print version.

Cite
Fathalla SE, Al-Jama AA, Al-Sheikh IH, et al. Seroepidemiological prevalence of hepatitis B virus markers in Eastern Saudi Arabia. Saudi Med J. 1998;19(3):283-288
Fathalla, S. E., Al-Jama, A. A., Al-Sheikh, I. H., El-Rifaei, A. M., Younis, Y. S., Badawi, M. S., Kanaan, A. M., & Sabry, H. S. (1998). Seroepidemiological prevalence of hepatitis B virus markers in Eastern Saudi Arabia. Saudi medical journal, 19(3), 283-288.
Fathalla, Sami E, et al. "Seroepidemiological prevalence of hepatitis B virus markers in Eastern Saudi Arabia." Saudi medical journal vol. 19,3 (1998): 283-288.
Fathalla SE, Al-Jama AA, Al-Sheikh IH, El-Rifaei AM, Younis YS, Badawi MS, Kanaan AM, Sabry HS. Seroepidemiological prevalence of hepatitis B virus markers in Eastern Saudi Arabia. Saudi Med J. 1998 May;19(3):283-288. PMID: 27701543.
Copy Download .nbib Format: NLM
Histolgical and immunohistochemical study on the effect of stem cell therapy on bleomycin induced pulmonary fibrosis in albino rat.

International journal of stem cells

Sabry MM, Elkalawy SA, Abo-Elnour RK, Abd-El-Maksod DF.
PMID: 24921026
Int J Stem Cells. 2014 May;7(1):33-42. doi: 10.15283/ijsc.2014.7.1.33.

AIM OF WORK: To demonstrate the bleomycin induced histological changes in the lung and the possible protective and/or therapeutic effect of stem cell therapy.MATERIALS AND METHODS: Study was carried out on 36 adult male albino rats, classified into 4...

Cite
Sabry MM, Elkalawy SA, Abo-Elnour RK, et al. Histolgical and immunohistochemical study on the effect of stem cell therapy on bleomycin induced pulmonary fibrosis in albino rat. Int J Stem Cells. 2014;7(1):33-42doi: 10.15283/ijsc.2014.7.1.33.
Sabry, M. M., Elkalawy, S. A., Abo-Elnour, R. K., & Abd-El-Maksod, D. F. (2014). Histolgical and immunohistochemical study on the effect of stem cell therapy on bleomycin induced pulmonary fibrosis in albino rat. International journal of stem cells, 7(1), 33-42. https://doi.org/10.15283/ijsc.2014.7.1.33
Sabry, Marwa Mohammed, et al. "Histolgical and immunohistochemical study on the effect of stem cell therapy on bleomycin induced pulmonary fibrosis in albino rat." International journal of stem cells vol. 7,1 (2014): 33-42. doi: https://doi.org/10.15283/ijsc.2014.7.1.33
Sabry MM, Elkalawy SA, Abo-Elnour RK, Abd-El-Maksod DF. Histolgical and immunohistochemical study on the effect of stem cell therapy on bleomycin induced pulmonary fibrosis in albino rat. Int J Stem Cells. 2014 May;7(1):33-42. doi: 10.15283/ijsc.2014.7.1.33. PMID: 24921026; PMCID: PMC4049730.
Copy Download .nbib Format: NLM
Therapeutic efficacy of differentiated versus undifferentiated mesenchymal stem cells in experimental type I diabetes in rat.

Biochemistry and biophysics reports

Wassef MA, Fouad H, Sabry D, Afifi N, Abbas AM, Mostafa W, Ahmed SH.
PMID: 28955854
Biochem Biophys Rep. 2016 Feb 09;5:468-475. doi: 10.1016/j.bbrep.2016.02.001. eCollection 2016 Mar.

Selective MSCs differentiation protocol into pancreatic beta cells was conducted in the present study using exendin-4 and TGF-beta. Differentiated and undifferentiated MSCs were assessed in experimental type I diabetes in rats. Ninety female white albino rats were included in...

Cite
Wassef MA, Fouad H, Sabry D, et al. Therapeutic efficacy of differentiated versus undifferentiated mesenchymal stem cells in experimental type I diabetes in rat. Biochem Biophys Rep. 2016;5:468-475doi: 10.1016/j.bbrep.2016.02.001.
Wassef, M. A., Fouad, H., Sabry, D., Afifi, N., Abbas, A. M., Mostafa, W., & Ahmed, S. H. (2016). Therapeutic efficacy of differentiated versus undifferentiated mesenchymal stem cells in experimental type I diabetes in rat. Biochemistry and biophysics reports, 5468-475. https://doi.org/10.1016/j.bbrep.2016.02.001
Wassef, M A, et al. "Therapeutic efficacy of differentiated versus undifferentiated mesenchymal stem cells in experimental type I diabetes in rat." Biochemistry and biophysics reports vol. 5 (2016): 468-475. doi: https://doi.org/10.1016/j.bbrep.2016.02.001
Wassef MA, Fouad H, Sabry D, Afifi N, Abbas AM, Mostafa W, Ahmed SH. Therapeutic efficacy of differentiated versus undifferentiated mesenchymal stem cells in experimental type I diabetes in rat. Biochem Biophys Rep. 2016 Feb 09;5:468-475. doi: 10.1016/j.bbrep.2016.02.001. eCollection 2016 Mar. PMID: 28955854; PMCID: PMC5600460.
Copy Download .nbib Format: NLM
A new antibacterial lupane ester from the seeds of Acokanthera oppositifolia Lam.

Natural product research

El Sayed AM, Ezzat SM, Sabry OM.
PMID: 27046822
Nat Prod Res. 2016 Dec;30(24):2813-2818. doi: 10.1080/14786419.2016.1166494. Epub 2016 Apr 04.

As a part of ongoing investigation of Acokanthera oppositifolia (Lam.) Codd., four compounds were isolated from its seeds, a new compound; lup-20(29)-en-3β-O-(3'-β-hydroxy) palmitate (1), three known compounds; a triterpene; lupeol (2), a cardiac glycoside; acovenoside A (3) and a...

Cite
El Sayed AM, Ezzat SM, Sabry OM. A new antibacterial lupane ester from the seeds of Acokanthera oppositifolia Lam. Nat Prod Res. 2016;30(24):2813-2818doi: 10.1080/14786419.2016.1166494.
El Sayed, A. M., Ezzat, S. M., & Sabry, O. M. (2016). A new antibacterial lupane ester from the seeds of Acokanthera oppositifolia Lam. Natural product research, 30(24), 2813-2818. https://doi.org/10.1080/14786419.2016.1166494
El Sayed, Abeer M, et al. "A new antibacterial lupane ester from the seeds of Acokanthera oppositifolia Lam." Natural product research vol. 30,24 (2016): 2813-2818. doi: https://doi.org/10.1080/14786419.2016.1166494
El Sayed AM, Ezzat SM, Sabry OM. A new antibacterial lupane ester from the seeds of Acokanthera oppositifolia Lam. Nat Prod Res. 2016 Dec;30(24):2813-2818. doi: 10.1080/14786419.2016.1166494. Epub 2016 Apr 04. PMID: 27046822.
Copy Download .nbib Format: NLM
Decreased expression of circulating microRNA-126 in patients with type 2 diabetic nephropathy: A potential blood-based biomarker.

Experimental and therapeutic medicine

Al-Kafaji G, Al-Mahroos G, Al-Muhtaresh HA, Skrypnyk C, Sabry MA, Ramadan AR.
PMID: 27446281
Exp Ther Med. 2016 Aug;12(2):815-822. doi: 10.3892/etm.2016.3395. Epub 2016 May 26.

Circulating microRNAs (miRNAs) have been proposed as promising biomarkers for multiple diseases. miR-126 is reported to be associated with type 2 diabetes mellitus (T2D), diabetic nephropathy (DN) and end stage renal disease. The aim of this study was to...

Cite
Al-Kafaji G, Al-Mahroos G, Al-Muhtaresh HA, et al. Decreased expression of circulating microRNA-126 in patients with type 2 diabetic nephropathy: A potential blood-based biomarker. Exp Ther Med. 2016;12(2):815-822doi: 10.3892/etm.2016.3395.
Al-Kafaji, G., Al-Mahroos, G., Al-Muhtaresh, H. A., Skrypnyk, C., Sabry, M. A., & Ramadan, A. R. (2016). Decreased expression of circulating microRNA-126 in patients with type 2 diabetic nephropathy: A potential blood-based biomarker. Experimental and therapeutic medicine, 12(2), 815-822. https://doi.org/10.3892/etm.2016.3395
Al-Kafaji, Ghada, et al. "Decreased expression of circulating microRNA-126 in patients with type 2 diabetic nephropathy: A potential blood-based biomarker." Experimental and therapeutic medicine vol. 12,2 (2016): 815-822. doi: https://doi.org/10.3892/etm.2016.3395
Al-Kafaji G, Al-Mahroos G, Al-Muhtaresh HA, Skrypnyk C, Sabry MA, Ramadan AR. Decreased expression of circulating microRNA-126 in patients with type 2 diabetic nephropathy: A potential blood-based biomarker. Exp Ther Med. 2016 Aug;12(2):815-822. doi: 10.3892/etm.2016.3395. Epub 2016 May 26. PMID: 27446281; PMCID: PMC4950785.
Copy Download .nbib Format: NLM
Bifidobacterium lactis in Treatment of Children with Acute Diarrhea. A Randomized Double Blind Controlled Trial.

Open access Macedonian journal of medical sciences

El-Soud NH, Said RN, Mosallam DS, Barakat NA, Sabry MA.
PMID: 27275258
Open Access Maced J Med Sci. 2015 Sep 15;3(3):403-7. doi: 10.3889/oamjms.2015.088. Epub 2015 Aug 07.

BACKGROUND: Probiotics are becoming increasingly popular treatment for children diarrhea. Although there are several probiotic strains potentially useful, researches were often limited to certain strains.AIM: To test Bifidobacterium lactis on morbidity of acute diarrhea in children less than 2...

Cite
El-Soud NH, Said RN, Mosallam DS, et al. Bifidobacterium lactis in Treatment of Children with Acute Diarrhea. A Randomized Double Blind Controlled Trial. Open Access Maced J Med Sci. 2015;3(3):403-7doi: 10.3889/oamjms.2015.088.
El-Soud, N. H., Said, R. N., Mosallam, D. S., Barakat, N. A., & Sabry, M. A. (2015). Bifidobacterium lactis in Treatment of Children with Acute Diarrhea. A Randomized Double Blind Controlled Trial. Open access Macedonian journal of medical sciences, 3(3), 403-7. https://doi.org/10.3889/oamjms.2015.088
El-Soud, Neveen Helmy Abou, et al. "Bifidobacterium lactis in Treatment of Children with Acute Diarrhea. A Randomized Double Blind Controlled Trial." Open access Macedonian journal of medical sciences vol. 3,3 (2015): 403-7. doi: https://doi.org/10.3889/oamjms.2015.088
El-Soud NH, Said RN, Mosallam DS, Barakat NA, Sabry MA. Bifidobacterium lactis in Treatment of Children with Acute Diarrhea. A Randomized Double Blind Controlled Trial. Open Access Maced J Med Sci. 2015 Sep 15;3(3):403-7. doi: 10.3889/oamjms.2015.088. Epub 2015 Aug 07. PMID: 27275258; PMCID: PMC4877827.
Copy Download .nbib Format: NLM
Relating circulating thyroid hormone concentrations to serum interleukins-6 and -10 in association with non-thyroidal illnesses including chronic renal insufficiency.

BMC endocrine disorders

Abo-Zenah HA, Shoeb SA, Sabry AA, Ismail HA.
PMID: 18211669
BMC Endocr Disord. 2008 Jan 22;8:1. doi: 10.1186/1472-6823-8-1.

BACKGROUND: Because of the possible role of cytokines including interleukins (IL) in systemic non-thyroidal illnesses' (NTI) pathogenesis and consequently the frequently associated alterations in thyroid hormone (TH) concentrations constituting the euthyroid sick syndrome (ESS), we aimed in this research...

Cite
Abo-Zenah HA, Shoeb SA, Sabry AA, et al. Relating circulating thyroid hormone concentrations to serum interleukins-6 and -10 in association with non-thyroidal illnesses including chronic renal insufficiency. BMC Endocr Disord. 2008;8:1doi: 10.1186/1472-6823-8-1.
Abo-Zenah, H. A., Shoeb, S. A., Sabry, A. A., & Ismail, H. A. (2008). Relating circulating thyroid hormone concentrations to serum interleukins-6 and -10 in association with non-thyroidal illnesses including chronic renal insufficiency. BMC endocrine disorders, 81. https://doi.org/10.1186/1472-6823-8-1
Abo-Zenah, Hamdy A, et al. "Relating circulating thyroid hormone concentrations to serum interleukins-6 and -10 in association with non-thyroidal illnesses including chronic renal insufficiency." BMC endocrine disorders vol. 8 (2008): 1. doi: https://doi.org/10.1186/1472-6823-8-1
Abo-Zenah HA, Shoeb SA, Sabry AA, Ismail HA. Relating circulating thyroid hormone concentrations to serum interleukins-6 and -10 in association with non-thyroidal illnesses including chronic renal insufficiency. BMC Endocr Disord. 2008 Jan 22;8:1. doi: 10.1186/1472-6823-8-1. PMID: 18211669; PMCID: PMC2254394.
Copy Download .nbib Format: NLM
Evidence for a parity doublet Delta(1920)P33 and Delta(1940)D33 from gammap-->ppi;{0}eta.

Physical review letters

Horn I, Anisovich AV, Anton G, Bantes R, Bartholomy O, Beck R, Beloglazov Y, Bogendörfer R, Castelijns R, Crede V, Ehmanns A, Ernst J, Fabry I, Flemming H, Fösel A, Fuchs M, Funke C, Gothe R, Gridnev A, Gutz E, Höffgen S, Hössl J, Junkersfeld J, Kalinowsky H, Klein F, Klempt E, Koch H, Konrad M, Kopf B, Krusche B, Langheinrich J, Löhner H, Lopatin I, Lotz J, Matthäy H, Menze D, Messchendorp J, Metag V, Nikonov VA, Novinski D, Ostrick M, van Pee H, Sarantsev AV, Schmidt C, Schmieden H, Schoch B, Suft G, Sumachev V, Szczepanek T, Thoma U, Walther D, Weinheimer C.
PMID: 19113330
Phys Rev Lett. 2008 Nov 14;101(20):202002. doi: 10.1103/PhysRevLett.101.202002. Epub 2008 Nov 12.

Evidence is reported for the existence of a parity doublet of Delta resonances with total angular momentum J=3/2 from photoproduction of the ppi;{0}eta final state. The two parity partners Delta(1920)P33 and Delta(1940)D33 make significant contributions to the reaction. Cascades...

Cite
Horn I, Anisovich AV, Anton G, et al. Evidence for a parity doublet Delta(1920)P33 and Delta(1940)D33 from gammap-->ppi;{0}eta. Phys Rev Lett. 2008;101(20):202002doi: 10.1103/PhysRevLett.101.202002.
Horn, I., Anisovich, A. V., Anton, G., Bantes, R., Bartholomy, O., Beck, R., Beloglazov, Y., Bogendörfer, R., Castelijns, R., Crede, V., Ehmanns, A., Ernst, J., Fabry, I., Flemming, H., Fösel, A., Fuchs, M., Funke, C., Gothe, R., Gridnev, A., Gutz, E., Höffgen, S., Hössl, J., Junkersfeld, J., Kalinowsky, H., Klein, F., Klempt, E., Koch, H., Konrad, M., Kopf, B., Krusche, B., Langheinrich, J., Löhner, H., Lopatin, I., Lotz, J., Matthäy, H., Menze, D., Messchendorp, J., Metag, V., Nikonov, V. A., Novinski, D., Ostrick, M., van Pee, H., Sarantsev, A. V., Schmidt, C., Schmieden, H., Schoch, B., Suft, G., Sumachev, V., Szczepanek, T., Thoma, U., Walther, D., Weinheimer, C. (2008). Evidence for a parity doublet Delta(1920)P33 and Delta(1940)D33 from gammap-->ppi;{0}eta. Physical review letters, 101(20), 202002. https://doi.org/10.1103/PhysRevLett.101.202002
Horn, I, et al. "Evidence for a parity doublet Delta(1920)P33 and Delta(1940)D33 from gammap-->ppi;{0}eta." Physical review letters vol. 101,20 (2008): 202002. doi: https://doi.org/10.1103/PhysRevLett.101.202002
Horn I, Anisovich AV, Anton G, Bantes R, Bartholomy O, Beck R, Beloglazov Y, Bogendörfer R, Castelijns R, Crede V, Ehmanns A, Ernst J, Fabry I, Flemming H, Fösel A, Fuchs M, Funke C, Gothe R, Gridnev A, Gutz E, Höffgen S, Hössl J, Junkersfeld J, Kalinowsky H, Klein F, Klempt E, Koch H, Konrad M, Kopf B, Krusche B, Langheinrich J, Löhner H, Lopatin I, Lotz J, Matthäy H, Menze D, Messchendorp J, Metag V, Nikonov VA, Novinski D, Ostrick M, van Pee H, Sarantsev AV, Schmidt C, Schmieden H, Schoch B, Suft G, Sumachev V, Szczepanek T, Thoma U, Walther D, Weinheimer C. Evidence for a parity doublet Delta(1920)P33 and Delta(1940)D33 from gammap-->ppi;{0}eta. Phys Rev Lett. 2008 Nov 14;101(20):202002. doi: 10.1103/PhysRevLett.101.202002. Epub 2008 Nov 12. PMID: 19113330.
Copy Download .nbib Format: NLM
Subcellular distribution of 2?,3?-cyclic nucleotide-3?-phosphodiesterase in cat peripheral nerve.

Neurochemistry international

Ross SM, Sabri MI, Spencer PS.
PMID: 20492965
Neurochem Int. 1985;7(4):601-6. doi: 10.1016/0197-0186(85)90056-7.

Subcellular distribution of 2?,3?-cyclic nucleotide-3?-phosphodiesterase (CNPase) in desheathed, saline perfused cat sciatic nerve is reported. CNPase specific activity was enriched in the total particulate (P(2)) fraction and was low in the soluble (S(2)) fraction. "Light-myelin" floating above the 0.60...

Cite
Ross SM, Sabri MI, Spencer PS. Subcellular distribution of 2?,3?-cyclic nucleotide-3?-phosphodiesterase in cat peripheral nerve. Neurochem Int. 1985;7(4):601-6doi: 10.1016/0197-0186(85)90056-7.
Ross, S. M., Sabri, M. I., & Spencer, P. S. (1985). Subcellular distribution of 2?,3?-cyclic nucleotide-3?-phosphodiesterase in cat peripheral nerve. Neurochemistry international, 7(4), 601-6. https://doi.org/10.1016/0197-0186(85)90056-7
Ross, S M, et al. "Subcellular distribution of 2?,3?-cyclic nucleotide-3?-phosphodiesterase in cat peripheral nerve." Neurochemistry international vol. 7,4 (1985): 601-6. doi: https://doi.org/10.1016/0197-0186(85)90056-7
Ross SM, Sabri MI, Spencer PS. Subcellular distribution of 2?,3?-cyclic nucleotide-3?-phosphodiesterase in cat peripheral nerve. Neurochem Int. 1985;7(4):601-6. doi: 10.1016/0197-0186(85)90056-7. PMID: 20492965.
Copy Download .nbib Format: NLM
Appropriateness of anemia management in hemodialysis patients.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society

Al-Ageel NA, Al-Aqeel SA, Abanmy NO, Alwakeel JS, Sabry A, Alsaran KA.
PMID: 23960781
Saudi Pharm J. 2012 Jan;20(1):85-91. doi: 10.1016/j.jsps.2011.08.007. Epub 2011 Sep 16.

UNLABELLED: The anemia of end stage renal disease (ESRD) is common and often severe complication that can be managed successfully by erythropoiesis-stimulating agents (ESA) administration.AIMS: To investigate current practice of anemia management in hemodialysis patients and to assess the...

Cite
Al-Ageel NA, Al-Aqeel SA, Abanmy NO, et al. Appropriateness of anemia management in hemodialysis patients. Saudi Pharm J. 2011;20(1):85-91doi: 10.1016/j.jsps.2011.08.007.
Al-Ageel, N. A., Al-Aqeel, S. A., Abanmy, N. O., Alwakeel, J. S., Sabry, A., & Alsaran, K. A. (2012). Appropriateness of anemia management in hemodialysis patients. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 20(1), 85-91. https://doi.org/10.1016/j.jsps.2011.08.007
Al-Ageel, Nahla A, et al. "Appropriateness of anemia management in hemodialysis patients." Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society vol. 20,1 (2012): 85-91. doi: https://doi.org/10.1016/j.jsps.2011.08.007
Al-Ageel NA, Al-Aqeel SA, Abanmy NO, Alwakeel JS, Sabry A, Alsaran KA. Appropriateness of anemia management in hemodialysis patients. Saudi Pharm J. 2012 Jan;20(1):85-91. doi: 10.1016/j.jsps.2011.08.007. Epub 2011 Sep 16. PMID: 23960781; PMCID: PMC3745195.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 252 entries